POWERING ADVANCEMENTS IN HEART HEALTH
The ability to detect cardiac biomarkers at ultra-low levels is advancing the future of heart health.
Simoa assays have the potential to detect cardiac biomarkers, which are instrumental for predicting major adverse cardiovascular events, development of heart failure or transition to end-stage kidney disease, earlier than ever before. Further, the ability to detect minute changes in these biomarkers could enable the identification of at-risk patients earlier in their disease progression to guide more personalized, preventive care.
Available for Scientific Research
|IL-6 (mouse)||NT-proBNP||TGFβ||TNFα||TNFα (mouse)|